Sphingosylphosphorylcholine (SPC) induces myosin light chain phosphorylation
スポンサーリンク
概要
- 論文の詳細を見る
- 日本平滑筋学会の論文
- 2003-04-27
著者
-
Kishi Hiroko
Department of Molecular Physiology and Medical Bioregulation, Yamaguchi University Graduate School o
-
Kobayashi Sei
Department of Molecular Physiology and Medical Bioregulation, Yamaguchi University Graduate School o
-
Wang Hongyan
Department Of Molecular Physiology Yamaguchi University School Of Medicine
-
Kishi Hiroko
Department Of Molecular Physiology Yamaguchi University School Of Medicine
-
Kishi Hiroko
Department Of Molecular Physiology
-
Kobayashi Sei
Department Of Molecular Physiology Yamaguchi University School Of Medicine
-
Kobayashi Sei
Department Of Molecular Physiology
-
Kishi Hiroko
Department of Molecular Physiology, Yamaguchi University School of Medicine
関連論文
- 7.The novel compounds which have inhibitory effect on the Ca^-independent abnormal vascular smooth muscle contraction to an extent comparable to the effects of eicosapentaenoic acid(Communication,Program and Abstracts of Papers for 48th Annual Meeting
- OE-302 Sphingomyelinase causes Endothelium-dependent Relaxation through Nitric Oxide Production and Hyperpolarization without Cytosolic Ca^ Elevation in Endothelial Cells in situ(Endothelium/NO 4 (H) : OE38)(Oral Presentation (English))
- A Novel Activation Mechanism of eNOS by Sphingolipid Mediators
- PE-230 A proteomic approach to identify novel signaling molecules mediating Ca^-sensitization of vascular smooth muscle contraction(Vascular Smooth Muscle 1 (H) : PE40)(Poster Session (English))
- Eicosapentaenoic Acid (EPA) Selectively Inhibits Ca^ Sensitization of Vascular Smooth Muscle through the Inhibition of Rho-Kinase Activity
- Sphingosylphosphorylcholine (SPC) and Src Family Tyrosine Kinase Are a Novel Messenger for Rho-Kinase-Mediated Ca^ Sensitization in Vascular Smooth Muscle Contraction
- Sphingosylphosphorylcholine is a novel messenger for Rho-kinase-mediated Ca^ of vascular Smooth Muscle : Involvement of Fyn, but not of PKC
- FRS-075 Cholesterol-enriched Membrane Rafts Provide a Novel Platform for Molecular Switch of the Signal Transduction of Abnormal Vascular Smooth Muscle Contraction(FRS16,Basic Mechanisms of Lipid Disorders and Metabolic Syndrome (H),Featured Research Sess
- PE-319 The Inhibitory Mechanism of Eicosapentaenoic Acid on the Ca^ Sensitization Mediated by SPC/Fyn/Rho-kinase Pathway, in Which Membrane Rafts are Involved(Vascular smooth muscles-2 (H) PE54,Poster Session (English),The 70th Anniversary Annual Scie
- Id2 Mediates Phenotypic Modulation of Vascular Smooth Muscle Cells by MAP Kinase Pathway
- OE-295 Fyn tyrosine kinase is a novel signal molecule of the Rho-kinase-mediated abnormal contraction of vascular smooth muscle(Vascular smooth muscle (IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Sphingosylphosphorylcholine (SPC) induces myosin light chain phosphorylation
- OE-195 The Role of Protein Tyrosine Kinase Fyn in Ca^ Sensitization of Vascular Smooth Muscle Contraction(Metabolism/Biochemistry/Energetics-1 (H) OE33,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulat
- OE-169 Fyn Tyrosine Kinase is a Novel Upstream Mediator for the Rhokinase-mediated Ca^-sensitization of Vascular Smooth Muscle Contraction Leading to Vasospasm(OE29,Molecular Biology Myocardium (M),Oral Presentation (English),The 73rd Annual Scientifi
- The involvement of Cholesterol and its Enriched Membrane Raft in Ca^ Sensitization Mediated by a Sphingosylphosphorylcholine/Src Family Tyrosine Kinase/Rho-kinase Pathway (Vascular Smooth Muscle 2 (H), The 69th Annual Scientific Meeting of the Japanes
- OE-294 The involvement of membrane rafts in the Ca^ sensitization of vascular smooth muscle contraction mediated by SPC/Fyn/ROK pathway(Vascular smooth muscle (IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulat
- Inhibitory Effects of ML-9, Wortmannin, and Y-27632 on the Chemotaxis of Vascular Smooth Muscle Cells in Response to Platelet-Derived Growth Factor-BB^1